GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age

Article Link: GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age

London, UK 21 May 2018 –GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance…

Source: FDA New Drug Approvals